For Healthcare Professionals

Treat the Infection, End the Frustration
Before they see you, most patients with onychomycosis try to treat the infection on their own. They become frustrated with ineffective treatment approaches. LAMISIL® Tablets offer effective treatment: high cure rates with low relapse, an established safety record, and convenient once-a-day dosing. In a 48-week assessment of clinical success rates with LAMISIL® Tablets, the following results were reported*:

	70% achieved mycologic cure
	59% achieved effective treatment (mycologic cure plus 0% nail involvement or 5 mm of new unaffected nail growth)
	38% achieved mycologic plus clinical cure after 12 weeks of therapy (one 250-mg tablet daily) [mean time to overall success: 10 months]
	85% did not relapse among those who achieved mycologic plus clinical cure of toenails (mycologic cure is achieved before clinical cure; relapse rate based on 38% of patients who demonstrated both mycologic cure plus clinical cure) Mycologic cure is achieved before clinical cure.

*LAMISIL® PI

To learn more about how LAMISIL® Tablets work, see Current Treatment Options for onychomycosis.

	Personalized Educational Materials for Your Patients
	You can print high-quality educational sheets about fungal nail infection to give to your patients, personalized with your practice name, address, phone numbers, and comments or special instructions. Just click on Patient Education Sheets to learn more.
	Who Is at Risk?
	Learn which patient groups have an increased susceptibility to onychomycosis. Early diagnosis and treatment are critical in these patient populations.